Region similarity and individual similarity across the three age groups: a) young (<30 years, b) middle-aged (≥30 & <60 years), and c) old age (≥60 years) for all cognitive systems... by Andrew Patton (10224161)

Sensitivity analysis heatmap for perturbations of 1%, 10%, and 50% in optimized parameters with Covid-19 data in Brazil. by Hélder Seixas Lima (18840636)

Lack of RSC3-reactive CD4 binding site IgG antibodies elicited in RV144 and RV305. by LaTonya D. Williams (3140490)

Comparison of virus fitness of variant rgC-A314G (K73R) and WT. by You-Yuan Tsai (3142086)

Temporal evolution of Covid-19 variants in Brazil. by Hélder Seixas Lima (18840636)

IgG binding magnitudes and response rates to vaccine-matched linear epitopes at RV305 week 2 and week 26. by LaTonya D. Williams (3140490)

Meta-analyses of COVIDST diagnostic accuracy. by Apoorva Anand (17921197)

“…Lower sensitivity was attributed to absence of symptoms, errors in test conduct and absence of supervision or a digital support. We found no difference in COVIDST sensitivity between delta and omicron pre-dominant period. …”

<i>Stay-at-home index</i> (Δ_<i>H</i>) reported for the Brazilian population during the Covid-19 pandemic. by Hélder Seixas Lima (18840636)

Comparative boxplots of effective reproduction number (<i>R</i>_<i>t</i>) similarity distributions in synthetic SIRDS outbreaks. by Hélder Seixas Lima (18840636)

SIRDS model simulations across three years for different basic reproduction numbers (<i>R</i>₀). by Hélder Seixas Lima (18840636)

Longitudinal YU2 gp120 WT-reactive CD4i IgG binding antibodies elicited in RV144 and RV305 (related to Fig 1). by LaTonya D. Williams (3140490)

Loss of <i>A</i>-homeostasis in the m7 controller with a random-order ternary-complex mechanism (Fig 51) when <i>k</i>₆ > <i>k</i>₅. by Qaiser Waheed (5095328)

“…(c) Decrease of <i>A</i> as a function of time when <i>k</i>₆=40.0. …”

Autophagic machinery is involved in cross-over endocytosis. by Nora Gehne (4357123)

“…<p><b>A</b>: Cocultures of mTurquoise2 (TRQ)-Cldn5 or LC3 labeled with red and green fluorescent protein (RFP-GFP-LC3) mono-transfected in Madin-Darby canine kidney cells II (MDCK-II). …”

A significant interaction of FC among cerebellar sub-regions and cerebral cortexes. by Mengling Shao (7450343)

“…The experimental group had stronger FC between left cerebellar hemispheric IV-V (A) and right cerebellar hemispheric VIII (B); between right cerebellar hemispheric VIII (B) and right hippocampus (C); between right cerebellar hemispheric VIII (B) and left middle cingulate gyrus (D); between cerebellar vermal IX (E) and right cerebellar hemispheric VIII (B) after training. …”

Bayesian evolutionary analysis of DENV-2 isolated from one patient in 2016 in Tainan, Taiwan. by You-Yuan Tsai (3142086)

Antibody-dependent cellular cytotoxicity (ADCC) activity reported as AUC. by LaTonya D. Williams (3140490)

Antibody-dependent cellular cytotoxicity (ADCC) of HIV-1-infected target cells is boosted by RV305 vaccination. by LaTonya D. Williams (3140490)

Illustration of the Susceptible-Infected-Recovered-Dead-Susceptible (SIRDS) model. by Hélder Seixas Lima (18840636)

Time-varying model parameters fitted for Covid-19 in Brazil. by Hélder Seixas Lima (18840636)

DataSheet1_A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days-a double-blind, randomized, three-arm, parallel-group, multi-center,... by Anju Majeed (19169428)

“…</p>Methods<p>Based on the inclusion/exclusion criteria, 105 newly diagnosed participants with degenerative hypertrophy OA were recruited and randomized into Placebo, BSE-150 mg or BSE-300 mg (n = 35 in each group) to receive either 150 mg or 300 mg BSE or a placebo tablet twice a day for 90 days. All the participants were evaluated for pain and physical function using the standard tools including the Visual Analog Scale (VAS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Lequesne Functional Index (LFI), EuroQol- 5 Dimension (EQ-5D) quality of life, 6-min walk test at day 0, days 5, 30, 60 and 90 of treatment. …”